Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MustGrow Biologics ( (TSE:MGRO) ) has issued an update.
MustGrow Biologics’ CEO reports that 2025 marked a shift from product development to commercialization, led by accelerating demand for its mustard-derived TerraSante biofertility product in the U.S. and initial sales through NexusBioAg in Canada. TerraSante has shown strong on-farm performance, including materially higher potato yields and quality with attractive return on investment, prompting the company to ramp up manufacturing capacity via Asian contract producers and plan dedicated, continuous production lines expected to enhance margins. Management also notes growing global interest from sales and distribution groups seeking to register TerraSante as a biofertility or biostimulant in other countries, positioning 2026 as a year of potentially significant sales growth and margin expansion, while the company advances TerraMG biopesticide registration efforts in Canada and the U.S. to build a broader biological crop input portfolio.
Spark’s Take on TSE:MGRO Stock
According to Spark, TipRanks’ AI Analyst, TSE:MGRO is a Neutral.
MustGrow Biologics’ overall stock score of 57 reflects significant revenue growth and strategic market expansions, countered by ongoing financial challenges and valuation concerns. The company’s strong gross margins and low leverage are positives, but the persistent net losses and negative cash flow remain crucial risks.
To see Spark’s full report on TSE:MGRO stock, click here.
More about MustGrow Biologics
MustGrow Biologics is a Canadian agri-biotechnology company focused on mustard-derived biological crop inputs, including biofertility and biopesticide products. Its primary offerings, such as the TerraSante biofertility line and the TerraMG biopesticide, target large-scale commercial farming operations, with an emphasis on improving yields and soil health in key North American agricultural markets and potentially abroad through distribution partners like NexusBioAg and international registrants.
Average Trading Volume: 23,315
Technical Sentiment Signal: Sell
Current Market Cap: C$32.37M
See more insights into MGRO stock on TipRanks’ Stock Analysis page.